5AM Partners VII reports Skye Bioscience share sale worth $64,858.44
5AM Partners VII, a 10% owner, sold 33,892 Skye Bioscience common shares on Sep. 16, 2026 at $1.91. Holdings fell to 142,463 shares held via 5AM Ventures II, LP; 5,616 via 5AM Co-Investors II, LP. 5AM Ventures VII, LP reported 981,269 shares beneficially owned following the filing. Disclaimer: This news brief was creat